Roxana Donisa Dreghici

Roxana Donisa Dreghici is an experienced healthcare professional with a strong background in clinical development and medical leadership within the biopharmaceutical industry. Currently serving as Vice President of Musculo-Skeletal at Edgewise Therapeutics since April 2024, Roxana previously held the position of Senior Vice President and Head of Clinical Development at Solid Biosciences from July 2021 to April 2024 and worked as Global Development Lead for Microdystrophin at Roche, focusing on Duchenne Muscular Dystrophy. Roxana’s extensive experience includes roles at Santhera Pharmaceuticals as Head of Medical Program for neuromuscular disorders, and various positions in clinical research with Novartis, Quintiles, Novo Nordisk, and Clinical Trial of Texas. Roxana earned a Doctor of Medicine degree from the University of Medicine and Pharmacy "Iuliu Hațieganu" Cluj-Napoca in Romania.